We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Neurology

Moderate Caffeinated Coffee and Tea Intake Linked to 18% Lower Dementia Risk in Decades-Long Study

MedXY Editorial Team•Feb 10, 2026•Neurology
caffeinecognitive healthDementianeurology

Highlights

  • Moderate caffeinated coffee consumption (2 to 3 cups/day) was associated with an 18% reduction in incident dementia risk compared to non-consumers.
  • Similar neuroprotective benefits were observed for tea consumption (1 to 2 cups/day), while decaffeinated coffee showed no significant association with cognitive outcomes.
  • The study, spanning over 40 years of follow-up, also linked higher caffeine intake to lower prevalence of subjective cognitive decline and improved objective cognitive scores.
  • Dose-response analysis revealed a non-linear relationship, suggesting that moderate intake provides the most pronounced benefit for brain health.

Background

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Navigating Surgical Decisions in Dementia: Challenges and Clinical InsightsClinicians face multifaceted challenges during surgical decision-making for patients with dementia, including difficulties in dementia recognition, reliance on caregivers, and lack of evidence-based guidelines, underscoring the need for impAug 23, 2026Navigating Surgical Decisions in Patients with Dementia: Clinician Challenges and InsightsThis article explores the complex challenges clinicians face in surgical decision-making for patients with dementia, highlighting issues with dementia identification, caregiver roles, and the influence of dementia on surgical outcomes.Aug 22, 2026Brain-Predicted Age Difference Enhances Dementia Risk Stratification in Subjective Cognitive Decline Beyond Standard MRI AssessmentBrain-predicted age difference (brain-PAD) from MRI improves early dementia risk prediction in patients with subjective cognitive decline, outperforming traditional visual MRI ratings and offering prognostic value beyond amyloid biomarkers,Aug 11, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Alzheimer and LATE-NC Pathologies Associated With Timely Dementia Diagnosis in Healthcare Settings
Among older adults with incident dementia, Alzheimer disease and LATE-NC pathologies were independently linked to higher odds of receiving a timely diagnosis, while vascular pathology and Lewy bodies showed no significant association.
Jul 26, 2026
SSRIs vs. Second-Generation Antipsychotics for Managing Agitation in Dementia: Real-World Evidence from Nursing HomesHighlight Agitation is prevalent among dementia patients in nursing homes, often managed with pharmacologic agents.…Jul 24, 2026
Unraveling Dementia in Severe Schizophrenia: Distinct Cognitive Profiles and Genetic InsightsThis study reveals that dementia in severe, treatment-resistant schizophrenia exhibits a unique cognitive profile distinct from common neurodegenerative dementias and lacks typical genetic markers such as APOE4, highlighting a novel dementiJun 30, 2026